Dentsply Sirona (XRAY) Q3 earnings report preview: what to look for
Dentsply Sirona (XRAY) is set to report Q3 earnings. Last quarter, it beat revenue and EPS estimates, with revenue at $898M, down 4.1% YoY. Analysts expect Q3 revenue to decline 4.9% YoY. The stock is up 14.1% over the last month, with an average price target of $12.40.
How this was made

The 30-second read
Why it matters
For traders, the actionable element is the upcoming earnings timing plus the direction of consensus (revenue expected to decline YoY) and the note that analysts have largely reconfirmed estimates.
Market read
XRAY is heading into earnings with consensus expecting a modest YoY revenue decline, while the stock has already rallied over the past month.
What to watch
The preview does not specify margin, cash flow, or guidance details for this quarter, which are often the true drivers of post-earnings repricing.
Background
The article is a pre-earnings preview for Dentsply Sirona’s Q3 report, referencing last quarter’s revenue/EPS beat and current consensus expectations.
Ticker impact
Dentsply Sirona is set to report Q3 earnings this Thursday, with the article citing expected revenue decline and recent estimate reconfirmations.
Likely limited upside unless revenue/EPS beat meaningfully versus the cited expectations, since the piece emphasizes consensus stability and a prior revenue-estimate track record.
The article provides a scheduled earnings catalyst and consensus direction (revenue down ~4.9% YoY) but does not introduce new guidance, prints, or surprises beyond preview-level context.
Market effects
Peers’ recent results (Henry Schein, Align Technology) are used as read-through, implying the healthcare equipment and supplies tape may influence XRAY’s earnings expectations.
No specific regional impact beyond US-listed healthcare equipment sentiment.
Limited, as the piece is US-focused and uses peer results as directional context rather than global macro drivers.
Counterpoint
If XRAY’s revenue decline is worse than the cited ~4.9% expectation, the stock’s prior month outperformance could make it vulnerable to a sharper post-earnings reset.
Key entities
- companyDentsply Sirona
NASDAQ-listed dental products company scheduled to report Q3 earnings Thursday afternoon.
- companyHenry Schein
Peer cited as having delivered YoY revenue growth in its Q3 results.
- companyAlign Technology
Peer cited as having reported revenues up YoY and topping estimates.





